Aug 6 (Reuters) - Bausch Health Companies Inc BHC.TO :
* QTRLY REVENUES OF $1.664 BILLION
* QTRLY LOSS PER SHARE $0.92
* BAUSCH HEALTH COMPANIES - NARROWED FY 2020 REVENUE AND ADJUSTED EBITDA (NON-GAAP) GUIDANCE RANGES PRIMARILY DUE TO THE IMPACT OF COVID-19 PANDEMIC
* NARROWED FULL-YEAR ADJUSTED EBITDA (NON-GAAP) RANGE FROM $3.15 - $3.35 BILLION TO $3.15 - $3.30 BILLION
* SEES NARROWED FULL-YEAR REVENUE RANGE FROM $7.80 – $8.20 BILLION TO $7.80 – $8.00 BILLION
* Q2 EARNINGS PER SHARE VIEW $0.67, REVENUE VIEW $1.79 BILLION -- REFINITIV IBES DATA
* FY2020 EARNINGS PER SHARE VIEW $3.82, REVENUE VIEW $8.06 BILLION -- REFINITIV IBES DATA